Thermopylae Holdings Ltd. has bought ABCL on 8 days since Nov 2021
10% owner at AbCellera Biologics Inc.
SEC CIK 0001834449 · Filings on SEC.gov ↗
Thermopylae Holdings Ltd.'s record
3 months after each buy, from the first price a copier could get.
8 buys since 2021 with 3 months of prices.
Every filing
9 filings since Jun 2021, newest first
Abcellera Biologics Inc.
10% owner
Abcellera Biologics Inc.
10% owner
Abcellera Biologics Inc.
10% owner
Abcellera Biologics Inc.
10% owner
Abcellera Biologics Inc.
10% owner
Abcellera Biologics Inc.
10% owner
Abcellera Biologics Inc.
10% owner
Abcellera Biologics Inc.
10% owner
Abcellera Biologics Inc.
10% owner
About Thermopylae Holdings Ltd.
Thermopylae Holdings Ltd. is a holding company incorporated under the Business Corporations Act of British Columbia, Canada, with its mailing address in Vancouver.( Established as a corporate entity (CENTRAL INDEX KEY: 0001834449), it operates primarily as an investment vehicle, notably as a 10% owner of AbCellera Biologics Inc. (ABCL).(
The company has actively traded ABCL shares, completing 11 transactions over the past five years, including 10 buys and 1 sell, with its most recent acquisition of 177,457 shares on February 26, 2026, at a weighted-average price of $3.27, increasing its holdings to 56,096,097 shares valued at approximately $171 million as of early 2026.( Thermopylae's investment strategy in ABCL demonstrates consistent accumulation, positioning it as a major shareholder.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.